v3.26.1
Condensed Consolidated Statements of Operations, Unaudited - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Revenues $ 0 $ 0 $ 0 $ 0
Costs and Expenses        
Operating expenses 2,125,000 1,892,000 2,860,000 11,404,000
Research and development expenses 9,000 104,000 11,000 151,000
Loss from operations (2,134,000) (1,996,000) (2,871,000) (11,555,000)
Other income (expense)        
Interest and financing expense (29,000) (143,000) (73,000) (258,000)
Net Loss $ (2,163,000) $ (2,139,000) $ (2,944,000) $ (11,813,000)
Net loss per common share, basic $ (0.00) $ (0.00) $ (0.01) $ (0.03)
Net loss per common share, diluted $ (0.00) $ (0.00) $ (0.01) $ (0.03)
Weighted average common shares outstanding, basic 556,762,727 495,547,582 552,055,120 467,026,067
Weighted average common shares outstanding, diluted 556,762,727 495,547,582 552,055,120 467,026,067

Source